115 related articles for article (PubMed ID: 3104057)
1. One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
Luoma PV; Heikkinen JE; Ehnholm C; Ylöstalo PR
Eur J Clin Pharmacol; 1987; 31(5):563-7. PubMed ID: 3104057
[TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
3. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
[TBL] [Abstract][Full Text] [Related]
4. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
Notelovitz M; Feldman EB; Gillespy M; Gudat J
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
[TBL] [Abstract][Full Text] [Related]
5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
7. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
Chambers DM; Jefferson GC; Chambers M; Loudon NB
Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
Larsson-Cohn U; Wallentin L; Zador G
Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
[TBL] [Abstract][Full Text] [Related]
9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose oral contraceptives on lipoproteins and lipolytic enzymes: differences between two commonly used preparations.
Leuven JA; Havekes L; van der Kooij-Pontier HA; Starmans RJ; Jansen H; Bouwhuis-Hoogerwerf ML; de Pagter HA; Hessel LW
Metabolism; 1984 Nov; 33(11):1039-42. PubMed ID: 6493047
[TBL] [Abstract][Full Text] [Related]
12. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
13. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
Mandal B; Maity CR
Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
[No Abstract] [Full Text] [Related]
14. Does progestogen reduction in oral contraception parallel reduced lipid metabolic effects?
Crona N; Silfverstolpe G; Samsioe G
Acta Obstet Gynecol Scand Suppl; 1982; 105():41-4. PubMed ID: 6805244
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
16. The clinical and biochemical effects of two combination oral contraceptive agents.
Sapire KE; Berger GM; Maritz JS
S Afr Med J; 1991 Apr; 79(7):376-9. PubMed ID: 1826569
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives, lipoproteins, and atherosclerosis.
Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
[TBL] [Abstract][Full Text] [Related]
18. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
Young RL; DelConte A
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):59-62. PubMed ID: 10561677
[TBL] [Abstract][Full Text] [Related]
20. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]